Table 4.
TIA % (95% CI) | Non-fatal stroke % (95% CI) | Non-fatal AMI % (95% CI) | CV mortality % (95% CI) | Composite CV outcomea % (95% CI) | Non-fatal venous thrombosis % (95% CI) | Overall mortality % (95% CI) | |
---|---|---|---|---|---|---|---|
Index TIA | |||||||
30-day | 0.37 (0.05–2.61) | – | – | 0.37 (0.05–2.60) | 0.74 (0.19–2.93) | – | 0.37 (0.05–2.60) |
90-day | 1.49 (0.56–3.92) | – | – | 0.37 (0.05–2.60) | 1.86 (0.78–4.40) | – | 0.37 (0.05–2.60) |
6-month | 1.87 (0.78–4.44) | – | – | 0.75 (0.19–2.96) | 2.61 (1.25–5.40) | – | 1.13 (0.37–3.46) |
12-month | 3.48 (1.82–6.58) | – | – | 0.75 (0.19–2.96) | 4.21 (2.35–7.47) | 0.79(0.20–3.12) | 1.92 (0.80–4.56) |
24-month | 6.57 (4.07–10.5) | – | 2.65 (1.20–5.80) | 1.65 (0.62–4.35) | 10.80 (7.47–15.5) | 1.24 (0.40–3.80) | 5.38 (3.15–9.09) |
60-month | 12.0 (8.26–17.2) | 1.24 (0.31–4.95) | 3.74 (1.88–7.40) | 2.14 (0.89–5.08) | 18.9 (14.2–24.9) | 3.68 (1.74–7.73) | 10.0 (6.69–14.9) |
Index stroke | |||||||
30-day | – | 0.31 (0.04–2.20) | 0.32 (0.04–2.23) | 1.55 (0.65–3.68) | 2.17 (1.04–4.50) | 0.63 (0.16–2.51) | 1.55 (0.65–3.68) |
90-day | – | 0.96 (0.31–2.95) | 0.32 (0.04–2.23) | 2.18 (1.04–4.51) | 3.44 (1.92–6.12) | 1.61 (0.67–3.83) | 2.18 (1.04–4.51) |
6-month | 0.67 (0.17–2.65) | 0.96 (0.31–2.95) | 0.32 (0.04–2.23) | 2.50 (1.26–4.94) | 4.41 (2.64–7.34) | 1.94 (0.88–4.27) | 2.50 (1.26–4.94) |
12-month | 2.04 (0.92–4.49) | 2.03 (0.92–4.47) | 0.67 (0.17–2.64) | 2.50 (1.26–4.94) | 7.14 (4.75–10.6) | 1.94 (0.88–4.27) | 2.84 (1.49–5.40) |
24-month | 2.86 (1.44–5.66) | 3.61 (1.96–6.63) | 0.67 (0.17–2.64) | 3.64 (2.02–6.49) | 10.2 (7.23–14.3) | 2.76 (1.38–5.46) | 6.67 (4.29–10.3) |
60-month | 5.81 (3.32–10.1) | 6.52 (3.90–10.8) | 1.80 (0.65–4.91) | 7.18 (4.52–11.3) | 19.2 (14.6–25.0) | 4.60 (2.46–8.49) | 20.4 (15.4–26.6) |
TIA transient ischemic attack, AMI acute myocardial infarction, CV cardiovascular
aComposite CV outcome includes non fatal TIA, Stroke, AMI, and CV deaths, whichever occurs first